Pacifica Partners’s VanEck Biotech ETF BBH Stock Holding History
Bought
Maintained
Sold
Other funds holding BBH
HFAS
Pacifica Partners's BBH Position: Q3 2026 in Review
Pacifica Partners held its VanEck Biotech ETF (BBH) position steady in Q3 2026 at 25 shares worth $5.96K. The position accounts for ﹤0.01% of the portfolio, ranked #325.
Pacifica Partners first reported a position in BBH in Q2 2021 and has held it in 22 quarters since. 19 funds tracked by Wall St. Rank hold BBH as of Q3 2026.
- Pacifica Partners held 25 shares of VanEck Biotech ETF worth $5.96K as of Q3 2026.
- Pacifica Partners left its VanEck Biotech ETF share count unchanged in Q3 2026.
- VanEck Biotech ETF made up ﹤0.01% of Pacifica Partners's portfolio in Q3 2026, its #325 holding.
- Pacifica Partners first reported a position in VanEck Biotech ETF in Q2 2021 and has held it in 22 quarters since.
- 19 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q3 2026.
Based on Pacifica Partners's 13F filing for Q3 2026, filed 9 Oct 2026.